Can an old anti-malarial drug be the center of a billion-dollar healthcare conversation? It already is. Hydroxychloroquine—once an under-the-radar treatment—has become a hot topic across the globe. But the hype is no longer just about pandemic headlines. The real story now is how its role in autoimmune treatment and chronic illness is triggering rapid growth in the...